John Glenn - 20 Jun 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Issuer symbol
IRMD
Transactions as of
20 Jun 2025
Net transactions value
-$82,235
Form type
4
Filing time
23 Jun 2025, 20:00:21 UTC
Previous filing
13 Dec 2024
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GLENN JOHN CHIEF FINANCIAL OFFICER C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS /s/ John Glenn 23 Jun 2025 0001253497

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +5,796 +66% 14,563 20 Jun 2025 Direct F1
transaction IRMD Common Stock Tax liability $82,235 -1,412 -9.7% $58.24 13,151 20 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -5,796 -50% $0.000000 5,796 20 Jun 2025 Common Stock 5,796 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis.
F2 On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.